Accelerating drug discovery and development with artificial intelligence
The story of Insilico Medicine and its cutting-edge AI platform that has demonstrated the potential to rapidly bring novel breakthrough medicines to patients while decreasing costs and increasing probabilities of success.
Sign in to ITAPA AI 2025
Ján Szöllös
InSilico Medicine
He started his professional career in artificial intelligence (AI) in Life Science in 2012 as a senior conference producer for Next Level Lifesciences. In 2019, he joined the Slovak startup Cognexa, dealing with the application of artificial intelligence in the automation of medical image processing, where he actively participated in the creatio…